#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Hormonal, metabolic and inflammatory circulating biomarker profiles in obese and non-obese Brazilian middle-aged women


Autoři: Leonardo Victor Galvão-Moreira aff001;  Anna Cyntia Brandão Nascimento aff002;  Izabella Mikaella Souza Campos D'Albuquerque aff001;  Marcus Antonio Silva Sousa aff001;  Haissa Oliveira Brito aff002;  Maria do Desterro Soares Brandão Nascimento aff002;  Maria Bethânia da Costa Chein aff002;  Luciane Maria Oliveira Brito aff002
Působiště autorů: School of Medicine, Federal University of Maranhão, São Luís, Brazil aff001;  Postgraduate Program in Adult Health, Federal University of Maranhão, São Luís, Brazil aff002
Vyšlo v časopise: PLoS ONE 14(9)
Kategorie: Research Article
doi: https://doi.org/10.1371/journal.pone.0222239

Souhrn

Aim

To investigate circulating hormonal, metabolic and inflammatory biomarker profiles in obese and non-obese middle-aged women.

Methods

A total of 110 women, aged 40–60 years, were included in this cross-sectional study. Patients were allocated, according to the occurrence of menopause and body mass index (BMI), into four groups: PM0 (premenopausal non-obese), PM1 (premenopausal obese), M0 (postmenopausal non-obese), and M1 (postmenopausal obese). Serum levels of gonadotropins, sex hormones, lipid markers, leptin, hs-CRP and interleukin-6 were obtained using either colorimetric or immunoenzymatic assays. Univariate and correlation analyses were performed among all clinical and laboratorial parameters. Principal component analysis was used to characterize subsets of biomarkers, which had their discriminatory capacity tested using discriminant function analysis.

Results

Levels of gonadotropins and female sex hormones were similar between PM0 and PM1 and between M0 and M1 (p > 0.05), all of them varied between PM0 and M0 (p < 0.05), but only estradiol was significantly altered in the comparison between PM1 and M1 (p = 0.027). Regarding metabolic markers, leptin was lower in PM0 than in M0 (p = 0.010) and higher in M1 than in M0 (p = 0.046). In premenopausal women, BMI correlated only to leptin, while it correlated to several other markers in postmenopausal women. A combination of FSH and leptin serum levels significantly discriminated the four groups (Wilks’s lambda < 0.001, in canonical functions 1 and 2).

Conclusion

A combined analysis of hormonal biomarkers may potentially distinguish obese from non-obese women with distinct menopause status. Further research is thus required to clarify the clinical significance of such findings.

Klíčová slova:

Biology and life sciences – Physiology – Physiological parameters – Obesity – Biochemistry – Hormones – Peptide hormones – leptin – Lipid hormones – estradiol – Progesterone – Biomarkers – Medicine and health sciences – Body weight – Body Mass Index – Endocrinology – Endocrine physiology – Menopause


Zdroje

1. Davis SR, Lambrinoudaki I, Lumsden M, Mishra GD, Pal L, Rees M et al. Menopause. Nat Rev Dis Primers. 2015;1:15004. doi: 10.1038/nrdp.2015.4 27188659

2. Levine ME, Lu AT, Chen BH, Hernandez DG, Singleton AB, Ferrucci L et al. Menopause accelerates biological aging. Proc Natl Acad Sci USA. 2016;113(33):9327–9332. doi: 10.1073/pnas.1604558113 27457926

3. Ossewaarde ME, Bots ML, Verbeek AL, Peeters PH, van der Graaf Y, Grobbee DE et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology. 2005;16(4):556–562. 15951675

4. Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM. Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017;67(5):378–397. doi: 10.3322/caac.21405 28763097

5. Kabat GC, Kim MY, Lee JS, Ho GY, Going SB, Beebe-Dimmer J et al. Metabolic obesity phenotypes and risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2017;26(12):1730–1735. doi: 10.1158/1055-9965.EPI-17-0495 28939589

6. Colpani V, Baena CP, Jaspers L, van Dijk GM, Farajzadegan Z, Dhana K et al. Lifestyle factors, cardiovascular disease and all-cause mortality in middle-aged and elderly women: a systematic review and meta-analysis. Eur J Epidemiol. 2018;33(9):831–845. doi: 10.1007/s10654-018-0374-z 29524110

7. Khalfa A, Tiali A, Zemour L, Fatah A, Mekki K. Prevalence of metabolic syndrome and its association with lifestyle and cardiovascular biomarkers among postmenopausal women in western Algeria. Int J Gynaecol Obstet. 2017;138(2):201–206. doi: 10.1002/ijgo.12206 28494104

8. Kabat GC, Wu WY, Bea JW, Chen C, Qi L, Stefanick ML et al. Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women. Int J Obes (Lond). 2017;41(1):170–177.

9. Çelik F, Belviranli M, Okudan N. Circulating levels of leptin, nesfatin-1 and kisspeptin in postmenopausal obese women. Arch Physiol Biochem. 2016;122(4):195–199. doi: 10.3109/13813455.2016.1171365 27011110

10. Ermakov S, Azarbal F, Stefanick ML, LaMonte MJ, Li W, Tharp KM et al. The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women. Heart. 2016;102(17):1354–1362. doi: 10.1136/heartjnl-2015-308927 27146694

11. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016;253:281–344. doi: 10.1016/j.atherosclerosis.2016.08.018 27594540

12. Tongdee P, Loyd RA, Kanoksin S, Kanjanawetang J, Winwan K, Nimkuntod P. Clinical usefulness of lipid ratios to identify subclinical atherosclerosis in perimenopausal/menopausal women. J Med Assoc Thai. 2016;99 Suppl 7:S36–S41.

13. Wang NC, Matthews KA, Barinas-Mitchell EJ, Chang CC, El Khoudary SR. Inflammatory/hemostatic biomarkers and coronary artery calcification in midlife women of African-American and White race/ethnicity: the Study of Women's Health Across the Nation (SWAN) heart study. Menopause. 2016;23(6):653–661. doi: 10.1097/GME.0000000000000605 27023861

14. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertil Steril. 2012;97(4):843–51. doi: 10.1016/j.fertnstert.2012.01.128 22341880

15. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, June 3–5, 1997. Geneva: WHO, 1998.

16. Nascimento JX, Chein MB, de Sousa RM, Ferreira Ados S, Navarro PA, Brito LM. Importance of lipid accumulation product index as a marker of CVD risk in PCOS women. Lipids Health Dis. 2015;14:62. doi: 10.1186/s12944-015-0061-y 26104466

17. Nogueira IAL, da Cruz ÉJSN, Fontenele AMM, Figueiredo Neto JÁ. Alterations in postmenopausal plasmatic lipidome. PLoS One. 2018;13(9):e0203027. doi: 10.1371/journal.pone.0203027 30180197

18. Branco-de-Almeida LS, Cruz-Almeida Y, Gonzalez-Marrero Y, Huang H, Aukhil I, Harrison P et al. Local and plasma biomarker profiles in localized aggressive periodontitis. JDR Clin Trans Res. 2017;2(3):258–268. doi: 10.1177/2380084417701898 28879248

19. Lizneva D, Rahimova A, Kim SM, Atabiekov I, Javaid S, Alamoush B et al. FSH beyond fertility. Front Endocrinol (Lausanne). 2019;10:136.

20. Zaidi M, Lizneva D, Kim SM, Sun L, Iqbal J, New MI et al. FSH, bone mass, body fat, and biological aging. Endocrinology. 2018;159(10):3503–3514. doi: 10.1210/en.2018-00601 30085049

21. Zaidi M, New MI, Blair HC, Zallone A, Baliram R, Davies TF et al. Actions of pituitary hormones beyond traditional targets. J Endocrinol. 2018;237(3):R83–R98. doi: 10.1530/JOE-17-0680 29555849

22. Liu P, Ji Y, Yuen T, Rendina-Ruedy E, DeMambro VE, Dhawan S et al. Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature. 2017;546(7656):107–112. doi: 10.1038/nature22342 28538730

23. Beydoun HA, Beydoun MA, Wiggins N, Stadtmauer L. Relationship of obesity-related disturbances with LH/FSH ratio among post-menopausal women in the United States. Maturitas. 2012;71(1):55–61. doi: 10.1016/j.maturitas.2011.10.010 22088801

24. Zsakai A, Karkus Z, Utczas K, Biri B, Sievert LL, Bodzsar EB. Body fatness and endogenous sex hormones in the menopausal transition. Maturitas. 2016;87:18–26. doi: 10.1016/j.maturitas.2016.02.006 27013284

25. Duggan C, Tapsoba JD, Stanczyk F, Wang CY, Schubert KF, McTiernan A. Long-term weight loss maintenance, sex steroid hormones, and sex hormone-binding globulin. Menopause. 2019;26(4):417–422. doi: 10.1097/GME.0000000000001250 30461557

26. Jones ME, Schoemaker MJ, Rae M, Folkerd EJ, Dowsett M, Ashworth A et al. Reproducibility of estradiol and testosterone levels in postmenopausal women over 5 years: results from the breakthrough generations study. Am J Epidemiol. 2014;179(9):1128–33. doi: 10.1093/aje/kwu027 24685533

27. Auro K, Joensuu A, Fischer K, Kettunen J, Salo P, Mattsson H et al. A metabolic view on menopause and ageing. Nat Commun. 2014;5:4708. doi: 10.1038/ncomms5708 25144627

28. Ke C, Hou Y, Zhang H, Yang K, Wang J, Guo B et al. Plasma metabolic profiles in women are menopause dependent. PLoS One. 2015;10(11):e0141743. doi: 10.1371/journal.pone.0141743 26580805

29. Veldhuis JD, Dyer RB, Trushin SA, Bondar OP, Singh RJ, Klee GG. Interleukins 6 and 8 and abdominal fat depots are distinct correlates of lipid moieties in healthy pre- and postmenopausal women. Endocrine. 2016;54(3):671–680. doi: 10.1007/s12020-016-1041-3 27444747

30. Nunes PRP, Martins FM, Souza AP, Carneiro MAS, Orsatti CL, Michelin MA et al. Effect of high-intensity interval training on body composition and inflammatory markers in obese postmenopausal women: a randomized controlled trial. Menopause. 2019;26(3):256–264. doi: 10.1097/GME.0000000000001207 30277921

31. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med. 2010;152(2):93–100. doi: 10.7326/0003-4819-152-2-201001190-00008 20083828

32. Gupta V, Mishra S, Mishra S, Kumar S, Gupta V. Association of Leptin: Adiponectin ratio and metabolic risk markers in postmenopausal women. Immunol Lett. 2018;196:63–67. doi: 10.1016/j.imlet.2018.01.008 29410303

33. Huang WY, Chang CC, Chen DR, Kor CT, Chen TY, Wu HM. Circulating leptin and adiponectin are associated with insulin resistance in healthy postmenopausal women with hot flashes. PLoS One. 2017;12(4):e0176430. doi: 10.1371/journal.pone.0176430 28448547


Článek vyšel v časopise

PLOS One


2019 Číslo 9
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Svět praktické medicíny 1/2024 (znalostní test z časopisu)
nový kurz

Koncepce osteologické péče pro gynekology a praktické lékaře
Autoři: MUDr. František Šenk

Sekvenční léčba schizofrenie
Autoři: MUDr. Jana Hořínková

Hypertenze a hypercholesterolémie – synergický efekt léčby
Autoři: prof. MUDr. Hana Rosolová, DrSc.

Význam metforminu pro „udržitelnou“ terapii diabetu
Autoři: prof. MUDr. Milan Kvapil, CSc., MBA

Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#